Xeris Biopharma Holdings Inc.

Stock Earnings

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Xeris Biopharma Holdings Inc’s recent filing unveils that its Director Schmid John P. acquired Company’s shares for reported $10147.0 on

Analysts Viewpoint

Xeris Biopharma Holdings Inc’s recently made public that its Director Schmid John P. acquired Company’s shares for reported $10147.0 on

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Xeris Biopharma Holdings Inc’s recently made public that its Director Schmid John P. acquired Company’s shares for reported $10147.0 on

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Xeris Biopharma Holdings Inc’s recent filing unveils that its Director Schmid John P. acquired Company’s shares for reported $10147.0 on

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

In a filing, Xeris Biopharma Holdings Inc revealed its Director Schmid John P. acquired Company’s shares for reported $10147.0 on

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Xeris Biopharma

Tag: Xeris Biopharma Holdings Inc.